Multiple Cancers gets Detected by New Blood Test

(The Quiver): A new blood test named Multi Cancer Early Detection (MCED) has effectively screened for numerous cancers in people who had not yet manifested any symptoms, which has the potential to revolutionize medical science. The test was administered to 6,662 people by GRAIL, a healthcare company focusing on enhancing cancer detection.

Due to their increased risk of developing cancer, the test was only administered to patients 50 years of age and older. the European Society for Medical Oncology (ESMO) Congress, test results were presented In Paris in 2022.

In this study, 11 cancer kinds that are currently not routinely screened were found, and the false positive rate was less than 1%. MD and Chief Medical Officer at GRAIL Jefferey Venstrom said.

The results of the test have been published for the first time.

When MCED testing was combined with conventional screening, the number of cancers found more than doubled. He added.

Both an older version of Galleri (MCED-E) and a more advanced version of Galleri were used to measure the Multi-Cancer Early Detection (MCED) test (MCED-Scr).

35 participants out of 92 patients who had the cancer signal were diagnosed with 36 different types of cancer. 71% of participants had cancer forms for which there is no available regular cancer screening.

Cancer signal origin prediction was 97% accurate, and most subjects saw their cancer diagnosis disappear after receiving clinical treatment in less than three months.